Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4258)
All Articles published online
|
Nov 28, 2009 (publication date) through Dec 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Li GQ, Xie J, Lei XY, Zhang L. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i44/5541.htm |
| Number | Citing Articles |
| 1 |
Fengyun Wen, Jin Zheng, Jing Yu, Mingju Gao, Sumin Gao, Yingying Zhou, Jianyu Liu, Zaiqing Yang. Macrophage migration inhibitory factor in the regulation of myoblast proliferation and differentiation. Bioscience, Biotechnology, and Biochemistry 2016; 80(7): 1313 doi: 10.1080/09168451.2016.1153951
|
| 2 |
Ramona Schulz-Heddergott, Ute M. Moll. MIF Family Cytokines in Innate Immunity and Homeostasis. 2017; : 21 doi: 10.1007/978-3-319-52354-5_2
|
| 3 |
Tasuku Matsuoka, Masakazu Yashiro. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma. Cancers 2014; 6(3): 1441 doi: 10.3390/cancers6031441
|
| 4 |
Justin C. Penticuff, Benjamin L. Woolbright, Thais M. Sielecki, Scott J. Weir, John A. Taylor. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential. Nature Reviews Urology 2019; 16(5): 318 doi: 10.1038/s41585-019-0171-9
|
| 5 |
Laura Ottini, Mario Falchetti, Gabriella Nesi. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. 2012; : 95 doi: 10.1007/978-1-61779-358-5_7
|
| 6 |
|
| 7 |
|
| 8 |
Xiao-bing Wang, Xiao-ying Tian, Yang Li, Bin Li, Zhi Li. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. Journal of Neuro-Oncology 2012; 106(1): 43 doi: 10.1007/s11060-011-0640-3
|
| 9 |
N J Shimwell, D G Ward, Y Mohri, T Mohri, L Pallan, M Teng, Y C Miki, M Kusunoki, O Tucker, W Wei, J Morse, P J Johnson. Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas. British Journal of Cancer 2012; 107(9): 1595 doi: 10.1038/bjc.2012.405
|
| 10 |
Zhenghou Zhang, Xiangyu Zhou, Jinshuai Guo, Fusheng Zhang, Yiping Qian, Guang Wang, Meiqi Duan, Yutian Wang, Haiying Zhao, Zhi Yang, Zunpeng Liu, Xiaofeng Jiang. TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03528-y
|
| 11 |
E Girard, C Strathdee, E Trueblood, C Quéva. Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model. British Journal of Cancer 2012; 107(9): 1498 doi: 10.1038/bjc.2012.392
|
| 12 |
Katherine T. Morris, Robert A. Nofchissey, Irina V. Pinchuk, Ellen J. Beswick, Pranela Rameshwar. Chronic Macrophage Migration Inhibitory Factor Exposure Induces Mesenchymal Epithelial Transition and Promotes Gastric and Colon Cancers. PLoS ONE 2014; 9(6): e98656 doi: 10.1371/journal.pone.0098656
|
| 13 |
Kusumawadee Utispan, Sittichai Koontongkaew. Macrophage migration inhibitory factor modulates proliferation, cell cycle, and apoptotic activity in head and neck cancer cell lines. Journal of Dental Sciences 2021; 16(1): 342 doi: 10.1016/j.jds.2020.02.008
|
| 14 |
Dawei Guo, Jinshuai Guo, Junchao Yao, Kun Jiang, Jianhua Hu, Bo Wang, Haiyang Liu, Lin Lin, Wenyu Sun, Xiaofeng Jiang. D‐dopachrome tautomerase is over‐expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth. International Journal of Cancer 2016; 139(9): 2056 doi: 10.1002/ijc.30278
|
| 15 |
Caroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Richard Bucala, Thuy T. Tran. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities. International Journal of Molecular Sciences 2024; 25(9): 4849 doi: 10.3390/ijms25094849
|
| 16 |
W K K Wu, C W Lee, C H Cho, D Fan, K Wu, J Yu, J J Y Sung. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010; 29(43): 5761 doi: 10.1038/onc.2010.352
|
| 17 |
Bing Liao, Bi‐ling Zhong, Zhi Li, Xiao‐ying Tian, Yang Li, Bin Li. Macrophage migration inhibitory factor contributes angiogenesis by up‐regulating IL‐8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. Journal of Surgical Oncology 2010; 102(7): 844 doi: 10.1002/jso.21728
|
| 18 |
Erin Skeens, Georgios Pantouris, Dilip Shah, Ramu Manjula, Michael J. Ombrello, N. Karl Maluf, Vineet Bhandari, George P. Lisi, Elias J. Lolis. A Cysteine Variant at an Allosteric Site Alters MIF Dynamics and Biological Function in Homo- and Heterotrimeric Assemblies. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.783669
|
| 19 |
Chad M. Thompson, Laurie C. Haws, Mark A. Harris, Nicole M. Gatto, Deborah M. Proctor. Application of the U.S. EPA Mode of Action Framework for Purposes of Guiding Future Research: A Case Study Involving the Oral Carcinogenicity of Hexavalent Chromium. Toxicological Sciences 2011; 119(1): 20 doi: 10.1093/toxsci/kfq320
|
| 20 |
Rong Fan, David Grignon, Erol E. Gulcicek, Philip Faught, Liang Cheng. Proteomic studies of Anaplasia in Wilms Tumor. Proteomics Insights 2011; 4 doi: 10.4137/PRI.S7466
|
| 21 |
MARIANA BARBOSA DE SOUZA, OTÁVIO ALBERTO CURIONI, JOSSI LEDO KANDA, MARCOS BRASILINO DE CARVALHO. Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma. Oncology Letters 2014; 8(5): 2267 doi: 10.3892/ol.2014.2513
|
| 22 |
Camila S Oliveira, Charles E de Bock, Timothy J Molloy, Elham Sadeqzadeh, Xin Yan Geng, Peter Hersey, Xu Dong Zhang, Rick F Thorne. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-630
|
| 23 |
Nadège Kindt, Fabrice Journe, Guy Laurent, Sven Saussez. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncology Letters 2016; 12(4): 2247 doi: 10.3892/ol.2016.4929
|
| 24 |
Kichul Yoon, Nayoung Kim, Youngmi Park, Bo Kyung Kim, Ji Hyun Park, Cheol Min Shin, Dong Ho Lee, Young-Joon Surh, Masaru Katoh. Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis. PLOS ONE 2019; 14(2): e0211736 doi: 10.1371/journal.pone.0211736
|
| 25 |
Aleksandra Butrym, Miroslaw Majewski, Justyna Dzietczenia, Kazimierz Kuliczkowski, Grzegorz Mazur. High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0560-5
|
| 26 |
Shuguang Wang, Xiaolei Li, Lianqi Yan, Qian Nie, Jihang Dai, Hui Chen, Jingcheng Wang, Yu Sun. Tamoxifen inhibits fibroblast proliferation and prevents epidural fibrosis by regulating the AKT pathway in rats. Biochemical and Biophysical Research Communications 2018; 497(4): 937 doi: 10.1016/j.bbrc.2018.01.032
|
| 27 |
Xu Wu, Jing Shen, Zhangang Xiao, Jing Li, Yueshui Zhao, Qijie Zhao, Chi Hin Cho, Mingxing Li. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets. Biochemical Pharmacology 2019; 163: 425 doi: 10.1016/j.bcp.2019.03.011
|
| 28 |
Xiao‑Yu Ma, Yu Ma, Huan Zhou, Hui‑Jing Zhang, Ming‑Jun Sun. Identification of the lncRNA‑miRNA‑mRNA network associated with gastric cancer via integrated bioinformatics analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10922
|
| 29 |
Denian Wang, Sixiang Li, Zhi Yang, Chunyan Yu, Pengfei Wu, Ying Yang, Rui Zhang, Qingyan Li, Jian Yang, Hongchun Li, Guiyi Ji, Yan Wang, Kang Xie, Yanyan Liu, Kaige Wang, Daxing Zhu, Wengeng Zhang, Dan Liu, Bojiang Chen, Weimin Li. Single‐cell transcriptome analysis deciphers the CD74‐mediated immune evasion and tumour growth in lung squamous cell carcinoma with chronic obstructive pulmonary disease. Clinical and Translational Medicine 2024; 14(8) doi: 10.1002/ctm2.1786
|
| 30 |
W Du, B M Wright, X Li, J Finke, B I Rini, M Zhou, H He, P Lal, S M Welford. Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma. Oncogene 2013; 32(11): 1469 doi: 10.1038/onc.2012.143
|
| 31 |
Yubiao Guo, Junna Hou, Yifeng Luo, Dujuan Wang. Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis. Cancer Cell International 2013; 13(1): 28 doi: 10.1186/1475-2867-13-28
|
| 32 |
Henu Kumar Verma, Yashwant Kumar Ratre, Pellegrino Mazzone, Simona Laurino, L. V. K. S. Bhaskar. Micro RNA facilitated chemoresistance in gastric cancer: a novel biomarkers and potential therapeutics. Alexandria Journal of Medicine 2020; 56(1): 81 doi: 10.1080/20905068.2020.1779992
|
| 33 |
Haixia Li, Jing Zang, Peng Wang, Liping Dai, Jianying Zhang, Kaijuan Wang. Gastric cancer susceptibility in gastric cancer relatives: Attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori. Cytokine 2012; 60(2): 346 doi: 10.1016/j.cyto.2012.07.015
|
| 34 |
Liang Duan, Liwei Ye, Rui Wu, Haiyan Wang, Xueru Li, Huan Li, Shimei Yuan, He Zha, Hui Sun, Yunyuan Zhang, Xian Chen, Yan Zhang, Lan Zhou. Inactivation of the Phosphatidylinositol 3‐Kinase/Akt Pathway is Involved in BMP9‐mediated Tumor‐suppressive Effects in Gastric Cancer Cells. Journal of Cellular Biochemistry 2015; 116(6): 1080 doi: 10.1002/jcb.25063
|
| 35 |
Peng Wei, Chen Zhiyu, Tang Xu, Zheng Xiangwei. Antitumor effect and apoptosis induction of Alocasia cucullata (Lour.) G. Don in human gastric cancer cells in vitro and in vivo. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0554-2
|
| 36 |
Z Zhang, Z Li, Y Li, A Zang. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Therapy 2014; 21(8): 305 doi: 10.1038/cgt.2014.37
|
| 37 |
Sha-sha Wang, Xiao Cen, Xin-hua Liang, Ya-ling Tang. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma. Oncotarget 2017; 8(6): 10650 doi: 10.18632/oncotarget.12890
|
| 38 |
Michael Thiele, Seamas C Donnelly, Robert A Mitchell. OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases. Journal for ImmunoTherapy of Cancer 2022; 10(9): e005475 doi: 10.1136/jitc-2022-005475
|
| 39 |
Sha‐Sha Wang, Min Zheng, Xin Pang, Mei Zhang, Xiang‐Hua Yu, Jing‐Biao Wu, Xiao‐Lei Gao, Jia‐Shun Wu, Xiao Yang, Ya‐Jie Tang, Ya‐Ling Tang, Xin‐Hua Liang. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein‐2/9. Molecular Carcinogenesis 2019; 58(10): 1809 doi: 10.1002/mc.23067
|
| 40 |
Georgios Giamas, Yik L. Man, Heidrun Hirner, Joachim Bischof, Klaus Kramer, Kalimullah Khan, Sharmeen S. Lavina Ahmed, Justin Stebbing, Uwe Knippschild. Kinases as targets in the treatment of solid tumors. Cellular Signalling 2010; 22(7): 984 doi: 10.1016/j.cellsig.2010.01.011
|
| 41 |
Laura Florez-Sampedro, Abel Soto-Gamez, Gerrit J. Poelarends, Barbro N. Melgert. The role of MIF in chronic lung diseases: looking beyond inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology 2020; 318(6): L1183 doi: 10.1152/ajplung.00521.2019
|